Erythromycin USP For Compounding (API)

Erythromycin USP for Compounding (API) is a pharmaceutical-grade antibiotic used primarily in the custom formulation of medications to treat various bacterial infections. It plays a crucial role in dermatology for addressing skin conditions like acne and rosacea, and in broader infectious disease management. This high-purity active pharmaceutical ingredient ensures adherence to stringent safety and efficacy standards, enabling healthcare providers to deliver personalized medicine. Through compounding, it helps achieve optimal health outcomes and enhances antibiotic stewardship in clinical practice.

Erythromycin USP is an antibiotic belonging to the macrolide class and serves as the active pharmaceutical ingredient in compounding formulations. It is commonly used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections. It works by inhibiting the growth of bacteria and preventing them from producing essential proteins needed for their survival. Erythromycin USP is available in various forms, including capsules, tablets, oral suspensions, ointments, and topical solutions, making it a versatile ingredient for compounding different formulations.